Clinical trial
Initial Assessment of the Effect of the Addition of Disulfiram (Antabuse) to…
NCT00312819 · Hadassah Medical Organization, Other · Completed
Key facts
| NCT number | NCT00312819 |
|---|---|
| Title | Initial Assessment of the Effect of the Addition of Disulfiram (Antabuse) to Standard Chemotherapy in Lung Cancer |
| Official title | Randomized Phase 2 Trial of Treatment of Advanced Non Small Cell Lung Carcinoma With/Without Disulfiram and Cisplatin Navelbine |
| Lead sponsor | Hadassah Medical Organization, Other |
| Collaborators | Augusta Hospital, Berlin |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Non-small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | chemotherapy +/- disulfiram |
| Enrollment | 60 |
| Start date | Mar 1, 2006 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Apr 11, 2006 |
| Last update posted | Aug 31, 2010 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: